Neue Suche | Kongressdetail
Druckansicht
 
 

Neuroimmunology Drug Development Summit

Evvnt Promotion / evvnt
-
27.04.2021 - 29.04.2021  Online
Time: 09:00 to 17:00
 
Kongressthemen
We present the Neuroimmunology Drug Development Summit, the industry's definitive and unrivalled forum focused on pushing the frontiers of targeting neuroinflammation for CNS Indications.

As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Andrea Crotti, Principal Scientist - Early Target Discovery, Takeda, Brad Friedman, Senior Scientist, Department of OMNI Bioinformatics, Genentech, Carlos Pedraza, Associate Director Neuroimmunology and MS Therapeutics, Sanofi, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/729873-2?pid=4832
Frau Sophie Ellis
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Conference + 2 Workshops: USD 2997.00, Conference + 1 Workshop: USD 2498.00, Conference Only: USD 2299.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteAMREF - African Medical and Research FoundationCharité International AcademyAlumni Club Medizinische Universität WienHilfswerk AustriaÖsterreichisches Rotes KreuzOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Anästhesie in Entwicklungsländern e. V.